Prospectively isolated cancer-associated CD10+fibroblasts have stronger interactions with CD133+colon cancer cells than with CD133-cancer cells

PLoS ONE

Volumn 5, Issue 8, 2010, Pages

  Cui, Lin ^a   Ohuchida, Kenoki ^a   Mizumoto, Kazuhiro ^a,b   Moriyama, Taiki ^a   Onimaru, Manabu ^a   Nakata, Kohei ^a   Nabae, Toshinaga ^a   Ueki, Takashi ^a   Sato, Norihiro ^a   Tominaga, Yohei ^a   Tanaka, Masao ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; MEMBRANE METALLOENDOPEPTIDASE; PEPTIDE; TUMOR MARKER;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN PURIFICATION; ARTICLE; BIOLOGICAL ACTIVITY; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CELL INTERACTION; CELL PROLIFERATION; CELL SPECIFICITY; CHEMOSENSITIVITY; COCULTURE; COLON CANCER; CONTROLLED STUDY; FEMALE; FIBROBLAST CULTURE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; TUMOR ASSOCIATED LEUKOCYTE; ANIMAL; CELL COMMUNICATION; CELL SEPARATION; COLON TUMOR; COMPARATIVE STUDY; FIBROBLAST; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; RECURRENT DISEASE; TUMOR CELL LINE;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIGENS, CD; CELL COMMUNICATION; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SEPARATION; COCULTURE TECHNIQUES; COLONIC NEOPLASMS; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GLYCOPROTEINS; HUMANS; MALE; MICE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEPRILYSIN; PEPTIDES; PROSPECTIVE STUDIES; RECURRENCE; TUMOR MARKERS, BIOLOGICAL;

EID: 77957874988     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012121     Document Type: Article

References (39)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, et al. (2006) Cancer statistics, 2006. CA Cancer J Clin 56: 106-130.
2. Kondo T (2007) Stem cell-like cancer cells in cancer cell lines. Cancer Biomark 3: 245-250.
3. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, et al. (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445: 111-115.
4. Miraglia S, Godfrey W, Yin AH, Atkins K, Warnke R, et al. (1997) A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 90: 5013-5021.
5. Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, et al. (1997) AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90: 5002-5012.
6. Weigmann A, Corbeil D, Hellwig A, Huttner WB (1997) Prominin, a novel microvilli-specific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells. Proc Natl Acad Sci U S A 94: 12425-12430.
7. Shmelkov SV, St Clair R, Lyden D, Rafii S (2005) AC133/CD133/Prominin-1. Int J Biochem Cell Biol 37: 715-719.
8. Richardson GD, Robson CN, Lang SH, Neal DE, Maitland NJ, et al. (2004) CD133, a novel marker for human prostatic epithelial stem cells. J Cell Sci 117: 3539-3545.
9. Kordes C, Sawitza I, Muller-Marbach A, Ale-Agha N, Keitel V, et al. (2007) CD133+ hepatic stellate cells are progenitor cells. Biochem Biophys Res Commun 352: 410-417.
10. Oshima Y, Suzuki A, Kawashimo K, Ishikawa M, Ohkohchi N, et al. (2007) Isolation of mouse pancreatic ductal progenitor cells expressing CD133 and c-Met by flow cytometric cell sorting. Gastroenterology 132: 720-732.
11. Sugiyama T, Rodriguez RT, McLean GW, Kim SK (2007) Conserved markers of fetal pancreatic epithelium permit prospective isolation of islet progenitor cells by FACS. Proc Natl Acad Sci U S A 104: 175-180.
12. O'Brien CA, Pollett A, Gallinger S, Dick JE (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445: 106-110.
13. Ieta K, Tanaka F, Haraguchi N, Kita Y, Sakashita H, et al. (2008) Biological and genetic characteristics of tumor-initiating cells in colon cancer. Ann Surg Oncol 15: 638-648.
14. Shmelkov SV, Butler JM, Hooper AT, Hormigo A, Kushner J, et al. (2008) CD133 expression is not restricted to stem cells, and both CD133+ and CD1332 metastatic colon cancer cells initiate tumors. J Clin Invest 118: 2111-2120.
15. Nomura S, Yoshitomi H, Takano S, Shida T, Kobayashi S, et al. (2008) FGF10/ FGFR2 signal induces cell migration and invasion in pancreatic cancer. Br J Cancer 99: 305-313.
16. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, et al. (2007) Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449: 557-563.
17. Deschauer M, Gizatullina Z, Schulze A, Pritsch M, Knoppel C, et al. (2006) Molecular and biochemical investigations in fumarase deficiency. Mol Genet Metab 88: 146-152.
18. Iwaya K, Ogawa H, Izumi M, Kuroda M, Mukai K (2002) Stromal expression of CD10 in invasive breast carcinoma: a new predictor of clinical outcome. Virchows Arch 440: 589-593.
19. Huang WB, Zhou XJ, Chen JY, Zhang LH, Meng K, et al. (2005) CD10-positive stromal cells in gastric carcinoma: correlation with invasion and metastasis. Jpn J Clin Oncol 35: 245-250.
20. Martin M, Pujuguet P, Martin F (1996) Role of stromal myofibroblasts infiltrating colon cancer in tumor invasion. Pathol Res Pract 192: 712-717.
21. Sreerama L, Sladek NE (2001) Primary breast tumor levels of suspected molecular determinants of cellular sensitivity to cyclophosphamide, ifosfamide, and certain other anticancer agents as predictors of paired metastatic tumor levels of these determinants. Rational individualization of cancer chemothera-peutic regimens. Cancer Chemother Pharmacol 47: 255-262.
22. Rich JN, Shi Q, Hjelmeland M, Cummings TJ, Kuan CT, et al. (2003) Bone-related genes expressed in advanced malignancies induce invasion and metastasis in a genetically defined human cancer model. J Biol Chem 278: 15951-15957.
23. Mendes O, Kim HT, Stoica G (2005) Expression of MMP2, MMP9 and MMP3 in breast cancer brain metastasis in a rat model. Clin Exp Metastasis 22: 237-246.
24. Renehan AG, Jones J, Potten CS, Shalet SM, O'Dwyer ST (2000) Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer. Br J Cancer 83: 1344-1350.
25. Huang EH, Hynes MJ, Zhang T, Ginestier C, Dontu G, et al. (2009) Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res 69: 3382-3389.
26. Todaro M, Alea MP, Di Stefano AB, Cammareri P, Vermeulen L, et al. (2007) Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 1: 389-402.
27. Chung LW, Kao C, Sikes RA, Zhau HE (1997) Human prostate cancer progression models and therapeutic intervention. Hinyokika Kiyo 43: 815-820.
28. McIntosh GG, Lodge AJ, Watson P, Hall AG, Wood K, et al. (1999) NCL-CD10-270: a new monoclonal antibody recognizing CD10 in paraffin-embedded tissue. Am J Pathol 154: 77-82.
29. Greaves MF, Hariri G, Newman RA, Sutherland DR, Ritter MA, et al. (1983) Selective expression of the common acute lymphoblastic leukemia (gp 100) antigen on immature lymphoid cells and their malignant counterparts. Blood 61: 628-639.
30. Imai K, Kanzaki H, Fujiwara H, Kariya M, Okamoto N, et al. (1992) Expression of aminopeptidase N and neutral endopeptidase on the endometrial stromal cells in endometriosis and adenomyosis. Hum Reprod 7: 1326-1328.
31. Ogawa H, Iwaya K, Izumi M, Kuroda M, Serizawa H, et al. (2002) Expression of CD10 by stromal cells during colorectal tumor development. Hum Pathol 33: 806-811.
32. Moreau I, Duvert V, Caux C, Galmiche MC, Charbord P, et al. (1993) Myofibroblastic stromal cells isolated from human bone marrow induce the proliferation of both early myeloid and B-lymphoid cells. Blood 82: 2396-2405.
33. Sato N, Mizumoto K, Beppu K, Maehara N, Kusumoto M, et al. (2000) Establishment of a new human pancreatic cancer cell line, NOR-P1, with high angiogenic activity and metastatic potential. Cancer Lett 155: 153-161.
34. Ohuchida K, Mizumoto K, Ohhashi S, Yamaguchi H, Konomi H, et al. (2007) Twist, a novel oncogene, is upregulated in pancreatic cancer: clinical implication of Twist expression in pancreatic juice. Int J Cancer 120: 1634-1640.
35. Ohuchida K, Mizumoto K, Ishikawa N, Fujii K, Konomi H, et al. (2005) The role of S100A6 in pancreatic cancer development and its clinical implication as a diagnostic marker and therapeutic target. Clin Cancer Res 11: 7785-7793.
36. Ohuchida K, Mizumoto K, Murakami M, Qian LW, Sato N, et al. (2004) Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions. Cancer Res 64: 3215-3222.
37. Ueda T, Yoshino H, Kobayashi K, Kawahata M, Ebihara Y, et al. (2000) Hematopoietic repopulating ability of cord blood CD34(+) cells in NOD/Shi-scid mice. Stem Cells 18: 204-213.
38. Antonov J, Goldstein DR, Oberli A, Baltzer A, Pirotta M, et al. (2005) Reliable gene expression measurements from degraded RNA by quantitative real-time PCR depend on short amplicons and a proper normalization. Lab Invest 85: 1040-1050.
39. Hoffmann AC, Mori R, Vallbohmer D, Brabender J, Klein E, et al. (2008) High expression of HIF1a is a predictor of clinical outcome in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA, VEGF, and bFGF. Neoplasia 10: 674-679.